Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Healthcare Biotechnology

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Post by Waco4505on Oct 06, 2020 10:43pm

352 Views

Post# 31678509

Dec 31????? Really???? Come on

5 hours ago — Health Canada approved another Abbott rapid test last week — the ID NOW, which is the molecular test that has been used at U.S. President Donald Trump's White House to screen staff since April. The government has said 2.5 million such tests will arrive by December 31, 2020. 2.5 million tests will be gone in 2 weeks.

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property